Novus Biologicals products are now on bio-techne.com

ILT5/CD85a/LILRB3 Antibody (222821) [Unconjugated]

Images

 
Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD14 PE‑conjugated Monoclonal Antibody (Catalog # FAB3832P) and either (A) Mouse Anti-Human LILRB3/CD85a/ILT5 Monoclonal Antibody ...read more

Product Details

Summary
Reactivity HuSpecies Glossary
Applications WB, Flow, CyTOF-ready
Clone
222821
Clonality
Monoclonal
Host
Mouse
Conjugate
Unconjugated

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

ILT5/CD85a/LILRB3 Antibody (222821) [Unconjugated] Summary

Immunogen
Mouse myeloma cell line NS0-derived recombinant human LILRB3/CD85a/ILT5
Gly24-Glu443
Accession # AAB68668
Specificity
Detects human LILRB3/CD85a/ILT5 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) ILT1, rhILT2, rhILT3, rhILT4, rhILT6, rhILT7 or rhILT11 is observed.
Source
N/A
Isotype
IgG2a
Clonality
Monoclonal
Host
Mouse
Gene
LILRB3
Purity Statement
Protein A or G purified from hybridoma culture supernatant
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Applications/Dilutions

Dilutions
  • CyTOF-ready
  • Flow Cytometry 0.25 ug/10^6 cells
  • Western Blot 1 ug/mL
Publications
Read Publications using
MAB1806 in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Reconstitution Instructions
Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for ILT5/CD85a/LILRB3 Antibody (222821) [Unconjugated]

  • CD85 antigen-like family member A
  • CD85a antigen
  • CD85a
  • HL9Immunoglobulin-like transcript 5
  • ILT5
  • ILT-5
  • ILT5CD85a
  • Leukocyte immunoglobulin-like receptor 3
  • leukocyte immunoglobulin-like receptor subfamily B member 3
  • leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains)
  • LILRB3
  • LIR3
  • LIR3CD85A
  • LIR-3MGC138403
  • member 3
  • Monocyte inhibitory receptor HL9
  • PIRB

Background

Immunoglobulin-Like Transcript 5 (ILT5), also known as Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB3), leukocyte immunoglobulin-Like Receptor 3 (LIR3) and CD85a, is an Ig-like receptor family member that is involved in immune regulation. ILT5 belongs to subfamily B whose members have cytoplasmic tails that contain Immunoreceptor Tyrosine-based Inhibitory Motifs (ITIMs) that inhibit signaling events via phosphatase SHP-1. The counterpart to subfamily B is subfamily A, whose members qualify as activating receptors that lack ITIMs, but signal through association with FcR gamma . ILTs share structural homology and chromosomal localization with the KIR family of receptors (1, 2). Mature ILT5 is a highly polymorphic 85‑95 kDa glycoprotein that consists of a 420 amino acid (aa) extracellular domain (ECD) with four Ig-like domains, a 21 aa transmembrane segment, and a 167 aa cytoplasmic domain with three ITIMs (3, 4). Alternate splicing generates an isoform with a 17 aa insertion in the juxtamembrane ECD. In mouse and rat, the LILRB3 gene encodes the PIR-B protein which has six Ig-like domains. Rodent PIR-B and human ILT5 share 55% aa sequence identity within common regions of their ECDs. Both PIR-B and ILT5 are receptors for S. aureus, and activation of these receptors by bacteria influences the innate immune response triggered by TLRs (4). ILT5 is expressed on the surface of peripheral monocytes, neutrophils, eosinophils, basophils, and mast cell progenitors but not on mature mast cells (5‑7). On basophils, cross-linking of ILT5 to the activating receptors ILT1/LIR7 or Fc epsilon RI inhibits the release of Histamine, Leukotriene C4, and IL-4 (6). On osteoclast precursors, ILT5 ligation inhibits RANKL or M-CSF induced differentiation (8). ILT5 is down‑regulated on macrophages in rheumatoid arthritis synovial tissue following successful treatment with DMARD anti-rheumatic drugs (9).

  1. Brown, D. et al. (2004) Tissue Antigens 64:215.
  2. Borges, L. and D. Cosman (2000) Cytokine Growth Factor Rev. 11:209.
  3. SwissProt Accession # O75022.
  4. Nakayama, M. et al. (2007) J. Immunol. 178:4250.
  5. Tedla, N. et al. (2003) Proc. Natl. Acad. Sci. 100:1174.
  6. Sloane, D.E. et al. (2004) Blood 104:2832.
  7. Tedla, N. et al. (2008) J. Leukoc. Biol. 83:334.
  8. Mori, Y. et al. (2008) J. Immunol. 181:4742.
  9. Huynh, O.A. et al. (2007) Rheumatology 46:742.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

MAB2754
Species: Mu
Applications: CyTOF-ready, Flow, WB
NBP2-67321
Species: Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, IP, WB
MAB2078
Species: Hu
Applications: CyTOF-ready, Flow, Neut, WB
NB100-524
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
NBP2-79843
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
7268-CT
Species: Hu
Applications: BA
MAB6364
Species: Hu
Applications: CyTOF-ready, Flow
MAB24251
Species: Hu
Applications: CyTOF-ready, Flow, WB
538-MG
Species: Rt
Applications: BA
6507-IL/CF
Species: Hu
Applications: BA
AF2425
Species: Hu
Applications: CyTOF-ready, Flow, WB
NBP2-22203
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
NBP2-41291
Species: Hu, Mu, Rt
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
AF3790
Species: Hu, Mu
Applications: ICC, Simple Western, WB

Publications for ILT5/CD85a/LILRB3 Antibody (MAB1806)(7)

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 3 applications: Flow Cytometry, Neutralization, Western Blot.


Filter By Application
Flow Cytometry
(5)
Neutralization
(2)
Western Blot
(1)
All Applications
Filter By Species
Human
(5)
Mouse
(1)
All Species
Showing Publications 1 - 7 of 7.
Publications using MAB1806 Applications Species
Wu G, Xu Y, Schultz RD et al. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-?B signaling axis Nature Cancer 2021-11-11 [PMID: 35122056]
MJ Yeboah, C Papagregor, DC Jones, HTC Chan, G Hu, JS McPartlan, T Schiött, UT Mattson, CI Mockridge, UC Tornberg, B Hambe, A Ljungars, M Mattsson, I Tews, MJ Glennie, SM Thirdborou, J Trowsdale, B Frendéus, J Chen, MS Cragg, A Roghanian LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation JCI Insight, 2020-09-01;0(0):. 2020-09-01 [PMID: 32870822] (Flow Cytometry, Mouse) Flow Cytometry Mouse
Huang J, Burke PS, Cung TD Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J. Virol., 2010-07-14;84(18):9463-71. 2010-07-14 [PMID: 20631139] (Neutralization, Human) Neutralization Human
Bankey PE, Banerjee S, Zucchiatti A, De M, Sleem RW, Lin CF, Miller-Graziano CL, De AK Cytokine induced expression of programmed death ligands in human neutrophils. Immunol. Lett., 2010-02-01;129(2):100-7. 2010-02-01 [PMID: 20123111] (Flow Cytometry, Human) Flow Cytometry Human
Pfistershammer K, Lawitschka A, Klauser C, Leitner J, Weigl R, Heemskerk MH, Pickl WF, Majdic O, Bohmig GA, Fischer GF, Greinix HT, Steinberger P Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood, 2009-07-17;114(11):2323-32. 2009-07-17 [PMID: 19617579] (Flow Cytometry, Human) Flow Cytometry Human
Mori Y, Tsuji S, Inui M, Sakamoto Y, Endo S, Ito Y, Fujimura S, Koga T, Nakamura A, Takayanagi H, Itoi E, Takai T Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. J. Immunol., 2008-10-01;181(7):4742-51. 2008-10-01 [PMID: 18802077] (Flow Cytometry, Neutralization, Western Blot, Human) Flow Cytometry, Neutralization, Western Blot Human
Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J. Exp. Med., 2007-04-09;204(4):907-20. 2007-04-09 [PMID: 17420263] (Flow Cytometry, Human) Flow Cytometry Human

Reviews for ILT5/CD85a/LILRB3 Antibody (MAB1806) (0)

There are no reviews for ILT5/CD85a/LILRB3 Antibody (MAB1806). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

Video Protocols

WB Video Protocol

FAQs for ILT5/CD85a/LILRB3 Antibody (MAB1806) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our ILT5/CD85a/LILRB3 Antibody (222821) [Unconjugated] and receive a gift card or discount.

Bioinformatics

Gene Symbol LILRB3
Uniprot